Evidence map›Paper›PMID 41465502›Full record

ReviewInternational journal of molecular sciences2025

Ensuring the Safe Use of Bee Products: A Review of Allergic Risks and Management.

Eliza Matuszewska-Mach, Paulina Borysewicz, Jan Królak, Magdalena Juzwa-Sobieraj, Jan Matysiak

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eliza Matuszewska-MachPoznan University of Medical Sciences, Department of Inorganic and Analytical Chemistry, Rokietnicka 3 Street, 60-806 Poznan, Poland.ORCID 0000-0002-5765-2603
Paulina BorysewiczPoznan University of Medical Sciences, The Students Scientific Society, Rokietnicka 5 Street, 60-806 Poznan, Poland.
Jan KrólakPoznan University of Medical Sciences, Department of Hypertensiology, Angiology and Internal Medicine, Długa 1/2 Street, 61-848 Poznan, Poland.ORCID 0000-0002-1211-625X
Magdalena Juzwa-SobierajPoznan University of Medical Sciences, Department of Pediatric Anesthesiology and Intensive Therapy, Carol Jonscher's Clinical Hospital, Szpitalna 27/33 Street, 60-572 Poznan, Poland.
Jan MatysiakPoznan University of Medical Sciences, Department of Inorganic and Analytical Chemistry, Rokietnicka 3 Street, 60-806 Poznan, Poland.ORCID 0000-0002-9993-1504

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honeybee products (HBPs), including honey, bee pollen, bee bread, royal jelly, propolis, beeswax, and bee brood, are increasingly used in food, nutraceutical, and cosmetic contexts. Because of their natural origin, HBPs can provoke allergic reactions ranging from localised dermatitis to life-threatening, systemic anaphylaxis. As the use of bee products for health purposes grows in apitherapy (a branch of alternative medicine), raising public awareness of their potential risks is essential. This narrative review synthesises the clinical manifestations of HBP allergy, culprit allergens present in each product, immunological mechanisms, diagnostic approaches, at-risk populations, and knowledge gaps. The analysis of the available literature suggests that, although relatively rarely, HPB may trigger allergic reactions, including anaphylactic shock. The sensitisation mechanism may be associated with both primary sensitisation and cross-reactivity and can be classified into type I (IgE-mediated) and type IV (T-cell-mediated). However, bee bread appears less allergenic than other HBPs, potentially due to lactic fermentation that can degrade allergenic proteins. Severe reactions following intake of bee bread have not been reported to date. Management of HBP allergic reactions centres on avoiding the products, educating about the risks, and providing more precise product labelling, specifying the allergen content. Individuals with atopy and beekeepers are at heightened risk of developing anaphylaxis; therefore, they should be particularly aware of the potential dangerous consequences of HPB use. Further research is needed to clarify the mechanisms of HBP allergies and improve safety for all users.

Indexed as

AllergensHypersensitivityAnimalsBeesHoneyHumansPollenPropolisAllergensPropolisallergensanaphylaxisfood hypersensitivityhoneybee products

Identifiers

PMID41465502
PMCPMC12732908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.